Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Restoring Emotional Stability through Neurofeedback and AI for Transformative Empowerment

Project description

AI-powered protocol to restore emotional stability

Emotion regulation (ER) is crucial for mental well-being. Disruptions in the brain’s ER circuitry are a transdiagnostic mechanism underlying a wide range of affective disorders, significantly contributing to the economic burden of mental health issues in Europe. Supported by the Marie Skłodowska-Curie Actions program, the RESoNATE project focuses on major depressive disorder, which is expected to become the leading cause of global disability by 2030. The project aims to validate the effectiveness of an electroencephalography (EEG) neurofeedback protocol that targets ER circuitry. It will also explore deep learning algorithms for EEG data analysis and investigate industrial potential through collaboration with a startup. RESoNATE seeks to advance mental health interventions and push the boundaries of AI methods.

Objective

Emotion regulation (ER) is the key to mental well-being. Disruptions in the brain ER circuitry is a transdiagnostic mechanism underpinning a wide spectrum of affective disorders that contribute to the mental health economic burden of 600 billion euros annually in Europe. This project focuses on Major Depressive Disorder (MDD), predicted to become the leading cause of global disability by 2030. Conventional treatment is ineffective for approximately 40-60% of patients, underscoring the crucial need for innovative therapeutic approaches. In this context, neurofeedback (NF) on ER with functional magnetic resonance imaging has emerged as a promising tool for the treatment of MDD in research settings. NF is a training that enables people to regulate their brain activity by providing real-time feedback on specific brain patterns, in this case on brain areas involved in ER. To bridge the gap between clinical practice and academic research, RESoNATE will validate the clinical effectiveness of an electroencephalography (EEG) NF protocol targeting ER circuitry. Going beyond the current state of the art, we will conduct a placebo-controlled study involving 72 MDD patients, stratified into NF, sham-NF(placebo), and control groups. A collaboration with the National Kaohsiung Medical University (Taiwan) will add a second NF dataset of 60 subjects. The second goal entails advancing the validation of novel deep learning algorithms for EEG time-series data analysis and testing generalization to different cultural datasets, deploying them to predict the success of NF—a key challenge within the field. By incorporating a startup into the project, we will explore the industrial potential of this research. As such, through RESoNATE and its objectives psychiatrists, psychologists, AI experts, and industrial innovators will come together to advance mental health interventions and explore the boundaries of state-of-the-art AI methods, unlocking new research avenues and market opportunities.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MSCA-2023-PF-01

See all projects funded under this call

Coordinator

UNIVERSITE DE STRASBOURG
Net EU contribution
€ 244 893,60
Address
RUE BLAISE PASCAL 4
67081 Strasbourg
France
Region
Grand Est Alsace Bas-Rhin
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Partners (2)